PBSerum Launch (Hong Kong)

Neu Era proudly marked another important milestone in its regional growth with the official launch of PBSerum in Hong Kong, reinforcing the company’s commitment to introducing innovative, science-led solutions to the aesthetic medical community across Asia.

The launch brought together aesthetic physicians, industry partners and medical professionals for an engaging programme focused on the science of recombinant enzyme technology, tissue remodelling and advanced aesthetic treatment strategies.

At the centre of the event was PBSerum, an innovative recombinant enzyme system developed to provide a targeted approach to tissue remodelling. Its differentiated enzymatic technology offers physicians a new way to address selected aesthetic concerns associated with fibrosis, scars, cellulite, skin laxity and altered tissue structure, while supporting treatment planning across a range of clinical applications.

The programme combined scientific education with practical clinical insight, giving participants the opportunity to better understand the technology behind PBSerum, its mechanism of action, treatment protocols and potential applications in everyday aesthetic practice. Through expert presentations, case sharing and clinical discussions, the event highlighted how recombinant enzymes can be incorporated into modern treatment strategies with a strong focus on precision, patient selection and outcome-driven care.

More than a product introduction, the Hong Kong launch reflected Neu Era’s wider philosophy of building brands through education, clinical support and meaningful partnerships with medical professionals. By equipping physicians with the knowledge and confidence to understand and apply new technologies appropriately, Neu Era aims to support the continued advancement of aesthetic medicine in the region.

The launch of PBSerum in Hong Kong also represents an important step in Neu Era’s regional expansion, strengthening its presence in one of Southeast Asia’s key aesthetic markets while creating new opportunities for ongoing physician training, workshops and clinical collaboration.

As Neu Era continues to grow its portfolio of innovative aesthetic solutions, the company remains focused on delivering technologies that are backed by science, supported by education and aligned with the evolving needs of both physicians and patients.

PBSerum Hong Kong — advancing tissue remodelling through recombinant enzyme technology.